Companies / Prometheus Biosciences, Inc.
Prometheus Biosciences, Inc.
RXDXCIK 1718852
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 8, 2023 | Cedars Sinai Intellectual Property Co 10% owner | Sell Open-market sale | Common Stock | $99.12M | -865K -17.78% | 4,001,132 | high |
| Mar 16, 2021 | Perceptive Advisors LLC 10% owner | Buy Open-market buy | Common Stock | $16.15M | +850K +34.50% | 3,314,032 | high |
| Mar 16, 2021 | Point72 Biotech Private Investments, LLC 10% owner | Buy Open-market buy | Common Stock | $15.20M | +800K +43.29% | 2,648,024 | high |
| Mar 16, 2021 | Rtw Investments, LLC 10% owner | Buy Open-market buy | Common Stock | $15.20M | +800K | 800,000 | high |
| Mar 16, 2021 | Cormorant Asset Management, LLC 10% owner | Buy Open-market buy | Common Stock | $7.13M | +375K +20.29% | 2,223,022 | high |
| Feb 16, 2023 | McKenna Mark C. CEO | Sell Open-market sale | Common Stock | $3.00M | -25K -31.19% | 55,144 | medium |
| Feb 15, 2023 | McKenna Mark C. CEO | Sell Open-market sale | Common Stock | $2.99M | -25K -31.19% | 55,144 | medium |
| Jan 17, 2023 | McKenna Mark C. CEO | Sell Open-market sale | Common Stock | $2.97M | -25K -31.19% | 55,144 | medium |